Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Daiichi Sankyo
>>
Phase 1
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
DS-8273
/ Daiichi Sankyo
agerafenib
(RXDX-105) / Roche, Daiichi Sankyo
AB-329
/ Baoyuan Biopharma
AMP-110
/ AstraZeneca, Daiichi Sankyo
DS-1093
/ Daiichi Sankyo
DS-7309
/ Daiichi Sankyo
PLX5622
/ Daiichi Sankyo
AC430
/ Daiichi Sankyo
AC708
/ Daiichi Sankyo
CS-0777
/ Daiichi Sankyo
DS-1055
/ Daiichi Sankyo
DS-1123
/ Daiichi Sankyo
DS-1150b
/ Daiichi Sankyo
DS-2248
/ Daiichi Sankyo
DS-2741a
/ Daiichi Sankyo
DS-3078
/ Daiichi Sankyo
DS-6016
/ Daiichi Sankyo
DS-6157
/ Daiichi Sankyo
DS-7080a
/ Daiichi Sankyo
DS-7423
/ Daiichi Sankyo
DS-9606
/ Daiichi Sankyo
IMU-856
/ Immunic
RO5212054
/ Daiichi Sankyo
RXDX-106
/ Roche
U3-1565
/ Daiichi Sankyo
U3-1784
/ Daiichi Sankyo
zeteletinib
(BOS-172738) / Boston Pharma
